Infliximab in cardiac sarcoidosis.

Back

ESC Premium Access

Infliximab in cardiac sarcoidosis.

Session: Cardiomyopathies: understanding the enemy

Topic: Heart failure, other

Speaker: Doctor R. Kandolin (Helsinki, FI)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Doctor Riina Kandolin

Helsinki University Central Hospital, Helsinki (Finland)

1 presentation

0 follower

8 more presentations in this session

First Australian registry of patients with wild type cardiac amyloidosis (ATTRwt): Queensland experience.

Speaker: Doctor M. Burrage (Brisbane, AU)

Clinical characteristics of ST-elevation and non-ST-elevation types in patients with takotsubo syndrome -a multicenter registry in eight-university hospitals in East Japan

Speaker: Assistant Professor M. Yoshizawa (Morioka, JP)

Myocardial bridging and left ventricular thrombus formation in patients with takotsubo cardiomyopathy

Speaker: Doctor B. Schneider (Luebeck, DE)

Access

Abstract

Risk factors for heart failure after doxorubicin chemotherapy for breast- or colorectal cancer

Speaker: Doctor G. Fogarassy (Balatonfured, HU)

Predictors of heart failure hospitalizations in hypertrophic cardiomyopathy

Speaker: Doctor A. Cecconi (Madrid, ES)

Access the full session

Cardiomyopathies: understanding the enemy

Speakers: Doctor R. Kandolin, Doctor M. Burrage, Assistant Professor M. Yoshizawa, Doctor B. Schneider, Doctor G. Fogarassy...

Access

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources